Heparan sulfate C5-epimerase is essential for heparin biosynthesis in mast cells. 2006

Thorsten B Feyerabend, and Jin-Ping Li, and Ulf Lindahl, and Hans-Reimer Rodewald
Department of Immunology, University of Ulm, D-89070 Ulm, Germany.

Biosynthesis of heparin, a mast cell-derived glycosaminoglycan with widespread importance in medicine, has not been fully elucidated. In biosynthesis of heparan sulfate (HS), a structurally related polysaccharide, HS glucuronyl C5-epimerase (Hsepi) converts D-glucuronic acid (GlcA) to L-iduronic acid (IdoA) residues. We have generated Hsepi-null mouse mutant mast cells, and we show that the same enzyme catalyzes the generation of IdoA in heparin and that 'heparin' lacking IdoA shows a distorted O-sulfation pattern.

UI MeSH Term Description Entries
D007067 Iduronic Acid Component of dermatan sulfate. Differs in configuration from glucuronic acid only at the C-5 position. Iduronate,Acid, Iduronic
D008407 Mast Cells Granulated cells that are found in almost all tissues, most abundantly in the skin and the gastrointestinal tract. Like the BASOPHILS, mast cells contain large amounts of HISTAMINE and HEPARIN. Unlike basophils, mast cells normally remain in the tissues and do not circulate in the blood. Mast cells, derived from the bone marrow stem cells, are regulated by the STEM CELL FACTOR. Basophils, Tissue,Basophil, Tissue,Cell, Mast,Cells, Mast,Mast Cell,Tissue Basophil,Tissue Basophils
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D008957 Models, Genetic Theoretical representations that simulate the behavior or activity of genetic processes or phenomena. They include the use of mathematical equations, computers, and other electronic equipment. Genetic Models,Genetic Model,Model, Genetic
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011134 Polysaccharides Long chain polymeric CARBOHYDRATES composed of MONOSACCHARIDES linked by glycosidic bonds. Glycan,Glycans,Polysaccharide
D002238 Carbohydrate Epimerases Enzymes that catalyze the epimerization of chiral centers within carbohydrates or their derivatives. EC 5.1.3. Carbohydrate Isomerases,Epimerases, Carbohydrate,Isomerases, Carbohydrate
D002240 Carbohydrate Sequence The sequence of carbohydrates within POLYSACCHARIDES; GLYCOPROTEINS; and GLYCOLIPIDS. Carbohydrate Sequences,Sequence, Carbohydrate,Sequences, Carbohydrate
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006497 Heparitin Sulfate A heteropolysaccharide that is similar in structure to HEPARIN. It accumulates in individuals with MUCOPOLYSACCHARIDOSIS. Heparan Sulfate,Sulfate, Heparan,Sulfate, Heparitin

Related Publications

Thorsten B Feyerabend, and Jin-Ping Li, and Ulf Lindahl, and Hans-Reimer Rodewald
June 2012, The Journal of biological chemistry,
Thorsten B Feyerabend, and Jin-Ping Li, and Ulf Lindahl, and Hans-Reimer Rodewald
June 2001, The Journal of biological chemistry,
Thorsten B Feyerabend, and Jin-Ping Li, and Ulf Lindahl, and Hans-Reimer Rodewald
January 2010, Progress in molecular biology and translational science,
Thorsten B Feyerabend, and Jin-Ping Li, and Ulf Lindahl, and Hans-Reimer Rodewald
October 1997, The Journal of biological chemistry,
Thorsten B Feyerabend, and Jin-Ping Li, and Ulf Lindahl, and Hans-Reimer Rodewald
October 2002, IUBMB life,
Thorsten B Feyerabend, and Jin-Ping Li, and Ulf Lindahl, and Hans-Reimer Rodewald
April 2006, The Journal of biological chemistry,
Thorsten B Feyerabend, and Jin-Ping Li, and Ulf Lindahl, and Hans-Reimer Rodewald
June 2001, The Journal of biological chemistry,
Thorsten B Feyerabend, and Jin-Ping Li, and Ulf Lindahl, and Hans-Reimer Rodewald
January 1989, Annals of the New York Academy of Sciences,
Thorsten B Feyerabend, and Jin-Ping Li, and Ulf Lindahl, and Hans-Reimer Rodewald
January 1977, Upsala journal of medical sciences,
Thorsten B Feyerabend, and Jin-Ping Li, and Ulf Lindahl, and Hans-Reimer Rodewald
July 2001, Archives of biochemistry and biophysics,
Copied contents to your clipboard!